Espra Capsule 20mg Indication
Espra Capsule 20mg is primarily indicated in conditions like Addisonian pernicious anaemia, Congenital cobalamine malabsorption, Congenital intrinsic factor deficiency, Homocystenemia, lleal resection, Methylmalonylacidurias, Nutrition deficiency, Post gastrectomy vit B-12 deficiency, Transcobalamin Il deficiency, and can also be given in adjunctive therapy as an alternative drug of choice in Infestations, Malignancy, Tapeworm infection, Vitamin-B12 defeciency of dietary origin.
The severe or irreversible adverse effects of Espra Capsule 20mg, which give rise to further complications include Congestive heart failure, Pulmonary edema, Thrombosis, Peripheral vascular disease.,Espra Capsule 20mg produces potentially life-threatening effects which include Hypersensitivity reactions, Shivering, Bronchospasm, Dyspnea, Persistant urticaria, Bronchospasm, which are responsible for the discontinuation of Espra Capsule 20mg therapy.,The symptomatic adverse reactions produced by Espra Capsule 20mg are more or less tolerable and if they become severe, they can be treated symptomatically, these include Diarrhea, Itching, Eczematous skin reaction.
Espra Capsule 20mg is contraindicated in conditions like Anaphylactic reactions, Tobacco amblyopia.
Espra Capsule 20mg should be used with caution in patients with suspected cobalt hypersensitivity, any pre-existing illnesses or any allergy. This medication should be used only as directed during pregnancy or lactation.